Physician profile
Daryl Altman
NPI 1538167648
$2,283.50
in general payments reported to CMS, 2019-2025
16 companies · $324 in 2025
The $324 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $318 · 2021: $330 · 2022: $375 · 2023: $370 · 2024: $407 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $995 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $995.28 |
| Education | $104.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $801.84 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Regeneron Healthcare Solutions, INC. | $515.73 | 2021-2025 | Dupixent |
| Genzyme Corporation | $283.84 | 2020-2023 | |
| Astrazeneca Pharmaceuticals Lp | $184.78 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Abbvie INC. | $124.92 | 2022 | |
| Amgen INC. | $112.15 | 2024-2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $44.95 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.84 | 2019 | |
| Merck Sharp & Dohme LLC | $34.63 | 2019-2021 | |
| Dexcom, INC. | $29.36 | 2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $25.74 | 2023 | |
| Phadia US INC. | $21.30 | 2022 | |
| Novo Nordisk INC | $19.29 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $18.64 | 2025 | Neffy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.60 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daryl Altman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.